Immunic, Inc.
IMUX· Nasdaq
Released Mar 4, 2019, after the close
10-K filed Mar 4, 2019, 63 days after period end · 0001280776-19-000025
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$4.81M | -$14.59M | -$11.73M | -$9.86M |
| EPS Diluted | -$5.68 | -$0.35 | -$0.37 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR